Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) |
11 Months Ended | 12 Months Ended |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2022 |
|
| Income Tax Disclosure [Abstract] | ||
| Statutory tax rate benefit | 19.00% | 19.00% |
| Non-deductible write-off of in-process R&D | (11.00%) | 0.00% |
| Other non-deductible expenses | (2.00%) | (3.00%) |
| Enhanced research and development expenses | 3.00% | 7.00% |
| Losses surrendered for tax incentive | (5.00%) | (7.00%) |
| Non-taxable research and development incentive | 2.00% | 1.00% |
| Research & development tax credits | 0.00% | 1.00% |
| Change in tax rate | 1.00% | 2.00% |
| Effect of overseas tax rates | 1.00% | 3.00% |
| Change in valuation allowance | (8.00%) | (23.00%) |
| Effective income tax rate | 0.00% | 0.00% |
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Losses Surrendered for Tax Incentive, Percent No definition available.
|
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Non-Taxable Research and Development, Percent No definition available.
|
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Nondeductible Expense, Write-off Of In-Process R&D No definition available.
|
| X | ||||||||||
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|